Indian firms seek 'practical approach' to avert impending EU API shutdown
This article was originally published in Scrip
Executive Summary
Even as India readies to comply with the EU's Falsified Medicines Directive, set to become applicable next year, domestic firms are keen that manufacturing units approved by the European Medicines Agency (EMEA) be exempt from the new requirements.